Anti-TRPM8/ LTRPC6/ LTrpC-6 monoclonal antibody

Anti-TRPM8/ LTRPC6/ LTrpC-6 antibody for FACS & in-vivo assay

Target products collectionGo to TRPM8/TRPM8 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T41955-Ab-1/ GM-Tg-hg-T41955-Ab-2Anti-Human TRPM8 monoclonal antibodyHuman
GM-Tg-rg-T41955-Ab-1/ GM-Tg-rg-T41955-Ab-2Anti-Rat TRPM8 monoclonal antibodyRat
GM-Tg-mg-T41955-Ab-1/ GM-Tg-mg-T41955-Ab-2Anti-Mouse TRPM8 monoclonal antibodyMouse
GM-Tg-cynog-T41955-Ab-1/ GM-Tg-cynog-T41955-Ab-2Anti-Cynomolgus/ Rhesus macaque TRPM8 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T41955-Ab-1/ GM-Tg-felg-T41955-Ab-2Anti-Feline TRPM8 monoclonal antibodyFeline
GM-Tg-cang-T41955-Ab-1/ GM-Tg-cang-T41955-Ab-2Anti-Canine TRPM8 monoclonal antibodyCanine
GM-Tg-bovg-T41955-Ab-1/ GM-Tg-bovg-T41955-Ab-2Anti-Bovine TRPM8 monoclonal antibodyBovine
GM-Tg-equg-T41955-Ab-1/ GM-Tg-equg-T41955-Ab-2Anti-Equine TRPM8 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T41955-Ab-1/ GM-Tg-hg-T41955-Ab-2; GM-Tg-rg-T41955-Ab-1/ GM-Tg-rg-T41955-Ab-2;
GM-Tg-mg-T41955-Ab-1/ GM-Tg-mg-T41955-Ab-2; GM-Tg-cynog-T41955-Ab-1/ GM-Tg-cynog-T41955-Ab-2;
GM-Tg-felg-T41955-Ab-1/ GM-Tg-felg-T41955-Ab-2; GM-Tg-cang-T41955-Ab-1/ GM-Tg-cang-T41955-Ab-2;
GM-Tg-bovg-T41955-Ab-1/ GM-Tg-bovg-T41955-Ab-2; GM-Tg-equg-T41955-Ab-1/ GM-Tg-equg-T41955-Ab-2
Products NameAnti-TRPM8 monoclonal antibody
Formatmab
Target NameTRPM8
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-TRPM8 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species TRPM8/ LTRPC6/ LTrpC-6 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMAP000103Human TRPM8 Adenovirus plasmid
    ORF Viral VectorvGMAP000103Human TRPM8 Adenovirus particle


    Target information

    Target IDGM-T41955
    Target NameTRPM8
    Gene ID79054,171382,171384,100429414,486170,101101245,541151,100057419
    Gene Symbol and SynonymsCMR1,LTrpC-6,LTRPC6,trp-p8,TRPM8,TRPP8
    Uniprot AccessionQ7Z2W7,Q8R455
    Uniprot Entry NameTRPM8_HUMAN,TRPM8_RAT
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000144481
    Target ClassificationN/A

    The target: TRPM8, gene name: TRPM8, also named as LTRPC6, LTrpC-6, TRPP8, trp-p8. Predicted to enable ligand-gated calcium channel activity. Predicted to be involved in calcium ion transmembrane transport and positive regulation of cold-induced thermogenesis. Predicted to act upstream of or within several processes, including cellular calcium ion homeostasis; response to cold; and thermoception. Located in plasma membrane. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.